Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 18

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Unraveling the Structural Changes in the DNA-Binding Region of Tumor Protein p53 (TP53) upon Hotspot Mutation p53 Arg248 by Comparative Computational Approach

Balasundaram, Ambritha, Doss, C. George Priya · 2022 · International Journal of Molecular Sciences

Abstract

The vital tissue homeostasis regulator p53 forms a tetramer when it binds to DNA and regulates the genes that mediate essential biological processes such as cell-cycle arrest, senescence, DNA repair, and apoptosis. Missense mutations in the core DNA-binding domain (109–292) simultaneously cause the loss of p53 tumor suppressor function and accumulation of the mutant p53 proteins that are carcinogenic. The most common p53 hotspot mutation at codon 248 in the DNA-binding region, where arginine (R) is substituted by tryptophan (W), glycine (G), leucine (L), proline (P), and glutamine (Q), is reported in various cancers. However, it is unclear how the p53 Arg248 mutation with distinct amino acid substitution affects the structure, function, and DNA binding affinity. Here, we characterized the pathogenicity and protein stability of p53 hotspot mutations at codon 248 using computational tools PredictSNP, Align GVGD, HOPE, ConSurf, and iStable. We found R248W, R248G, and R248P mutations highly deleterious and destabilizing. Further, we subjected all five R248 mutant-p53–DNA and wt-p53–DNA complexes to molecular dynamics simulation to investigate the structural stability and DNA binding affinity. From the MD simulation analysis, we observed increased RMSD, RMSF, and Rg values and decreased protein–DNA intermolecular hydrogen bonds in the R248-p53–DNA than the wt-p53–DNA complexes. Likewise, due to high SASA values, we observed the shrinkage of proteins in R248W, R248G, and R248P mutant-p53–DNA complexes. Compared to other mutant p53–DNA complexes, the R248W, R248G, and R248P mutant-p53–DNA complexes showed more structural alteration. MM-PBSA analysis showed decreased binding energies with DNA in all five R248-p53–DNA mutants than the wt-p53–DNA complexes. Henceforth, we conclude that the amino acid substitution of Arginine with the other five amino acids at codon 248 reduces the p53 protein’s affinity for DNA and may disrupt cell division, resulting in a gain of p53 function. The proposed study influences the development of rationally designed molecular-targeted treatments that improve p53-based therapeutic outcomes in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms232415499

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 91

  1. Sigal, 2000, Oncogenic Mutations of the P53 Tumor Suppressor: The Demons of the Guardian of the Genome, Cancer Res., 60, 6788
  2. Vousden, 2002, Live or Let Die: The Cell’s Response to P53, Nat. Rev. Cancer, 2, 594, 10.1038/nrc864 · DOI · Paper page
  3. Mogi, 2011, TP53 Mutations in Nonsmall Cell Lung Cancer, J. Biomed. Biotechnol., 2011, e583929
  4. May, 1999, Twenty Years of P53 Research: Structural and Functional Aspects of the P53 Protein, Oncogene, 18, 7621, 10.1038/sj.onc.1203285 · DOI · Paper page
  5. Gottlieb, 1998, P53 and Apoptosis, Semin. Cancer Biol., 8, 359, 10.1006/scbi.1998.0098 · DOI · Paper page
  6. Zhao, 2000, Analysis of P53-Regulated Gene Expression Patterns Using Oligonucleotide Arrays, Genes Dev., 14, 981, 10.1101/gad.14.8.981 · DOI · Paper page
  7. Blandino, 2018, New Therapeutic Strategies to Treat Human Cancers Expressing Mutant P53 Proteins, J. Exp. Clin. Cancer Res., 37, 30, 10.1186/s13046-018-0705-7 · DOI · Paper page
  8. Hou, 2019, Concurrent TP53 Mutations Predict Poor Outcomes of EGFR-TKI Treatments in Chinese Patients with Advanced NSCLC, Cancer Manag. Res., 11, 5665, 10.2147/CMAR.S201513 · DOI
  9. Zhao, 2007, TP53mutation Status and Gene Expression Profiles Are Powerful Prognostic Markers of Breast Cancer, Cancer Manag. Res., 9, R30
  10. Soussi, 2005, The P53 Pathway and Human Cancer, Br. J. Surg., 92, 1331, 10.1002/bjs.5177 · DOI
  11. Friedler, 2005, Modulation of Binding of DNA to the C-Terminal Domain of P53 by Acetylation, Structure, 13, 629, 10.1016/j.str.2005.01.020 · DOI · Paper page
  12. Kamaraj, B., and Bogaerts, A. (2015). Structure and Function of P53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study. PLoS ONE, 10. · DOI
  13. Madapura, 2012, P53 Contributes to T Cell Homeostasis through the Induction of Pro-Apoptotic SAP, Cell Cycle, 11, 4563, 10.4161/cc.22810 · DOI
  14. Tate, 2019, COSMIC: The Catalogue of Somatic Mutations in Cancer, Nucleic Acids Res., 47, D941, 10.1093/nar/gky1015 · DOI · Paper page
  15. Prives, 2012, Mutant P53: One Name, Many Proteins, Genes Dev., 26, 1268, 10.1101/gad.190678.112 · DOI · Paper page
  16. Leroy, 2013, The TP53 Website: An Integrative Resource Centre for the TP53 Mutation Database and TP53 Mutant Analysis, Nucleic Acids Res., 41, D962, 10.1093/nar/gks1033 · DOI · Paper page
  17. Muller, 2013, P53 Mutations in Cancer, Nat. Cell Biol., 15, 2, 10.1038/ncb2641 · DOI · Paper page
  18. Klemke, 2021, The Gain-of-Function P53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells, Front. Oncol., 11, 642603, 10.3389/fonc.2021.642603 · DOI
  19. Yoshikawa, 2010, Mutant P53 R248Q but Not R248W Enhances in Vitro Invasiveness of Human Lung Cancer NCI-H1299 Cells, Biomed. Res., 31, 401, 10.2220/biomedres.31.401 · DOI
  20. Li, 2014, Mutants TP53 p.R273H and p.R273C but Not p.R273G Enhance Cancer Cell Malignancy, Hum. Mutat., 35, 575, 10.1002/humu.22528 · DOI
  21. Olivier, 2006, The Clinical Value of Somatic TP53 Gene Mutations in 1,794 Patients with Breast Cancer, Clin. Cancer Res., 12, 1157, 10.1158/1078-0432.CCR-05-1029 · DOI · Paper page
  22. Seagle, 2015, Survival of Patients with Structurally-Grouped TP53 Mutations in Ovarian and Breast Cancers, Oncotarget, 6, 18641, 10.18632/oncotarget.4080 · DOI
  23. Bykov, 2014, Mutant P53 Reactivation by Small Molecules Makes Its Way to the Clinic, FEBS Lett., 588, 2622, 10.1016/j.febslet.2014.04.017 · DOI · Paper page
  24. Mantovani, 2019, Mutant P53 as a Guardian of the Cancer Cell, Cell Death Differ., 26, 199, 10.1038/s41418-018-0246-9 · DOI · Paper page
  25. Bendl, J., Stourac, J., Salanda, O., Pavelka, A., Wieben, E.D., Zendulka, J., Brezovsky, J., and Damborsky, J. (2014). PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations. PLOS Comput. Biol., 10. · DOI · Paper page
  26. Tavtigian, 2006, Comprehensive Statistical Study of 452 BRCA1 Missense Substitutions with Classification of Eight Recurrent Substitutions as Neutral, J. Med. Genet., 43, 295, 10.1136/jmg.2005.033878 · DOI · Paper page
  27. Venselaar, H., te Beek, T.A., Kuipers, R.K., Hekkelman, M.L., and Vriend, G. (2010). Protein Structure Analysis of Mutations Causing Inheritable Diseases. An e-Science Approach with Life Scientist Friendly Interfaces. BMC Bioinform., 11. · DOI · Paper page
  28. Chen, C.-W., Lin, J., and Chu, Y.-W. (2013). IStable: Off-the-Shelf Predictor Integration for Predicting Protein Stability Changes. BMC Bioinform., 14. · DOI · Paper page
  29. Pronk, 2013, GROMACS 4.5: A High-Throughput and Highly Parallel Open Source Molecular Simulation Toolkit, Bioinformatics, 29, 845, 10.1093/bioinformatics/btt055 · DOI · Paper page
  30. Stone, 2005, Physicochemical Constraint Violation by Missense Substitutions Mediates Impairment of Protein Function and Disease Severity, Genome Res., 15, 978, 10.1101/gr.3804205 · DOI · Paper page
  31. Ramensky, 2002, Human Non-synonymous SNPs: Server and Survey, Nucleic Acids Res., 30, 3894, 10.1093/nar/gkf493 · DOI · Paper page
  32. Capriotti, 2006, Predicting the Insurgence of Human Genetic Diseases Associated to Single Point Protein Mutations with Support Vector Machines and Evolutionary Information, Bioinformatics, 22, 2729, 10.1093/bioinformatics/btl423 · DOI · Paper page
  33. Sim, 2012, SIFT Web Server: Predicting Effects of Amino Acid Substitutions on Proteins, Nucleic Acids Res., 40, W452, 10.1093/nar/gks539 · DOI · Paper page
  34. Bromberg, 2007, SNAP: Predict Effect of Non-Synonymous Polymorphisms on Function, Nucleic Acids Res., 35, 3823, 10.1093/nar/gkm238 · DOI · Paper page
  35. Bao, 2005, NsSNPAnalyzer: Identifying Disease-Associated Nonsynonymous Single Nucleotide Polymorphisms, Nucleic Acids Res., 33, W480, 10.1093/nar/gki372 · DOI · Paper page
  36. Thomas, 2004, Coding Single-Nucleotide Polymorphisms Associated with Complex vs. Mendelian Disease: Evolutionary Evidence for Differences in Molecular Effects, Proc. Natl. Acad. Sci. USA, 101, 15398, 10.1073/pnas.0404380101 · DOI · Paper page
  37. Adzhubei, 2010, A Method and Server for Predicting Damaging Missense Mutations, Nat. Methods, 7, 248, 10.1038/nmeth0410-248 · DOI · Paper page
  38. Mathe, 2006, Computational Approaches for Predicting the Biological Effect of P53 Missense Mutations: A Comparison of Three Sequence Analysis Based Methods, Nucleic Acids Res., 34, 1317, 10.1093/nar/gkj518 · DOI · Paper page
  39. Cheng, 2006, Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, Proteins Struct. Funct. Bioinform., 62, 1125, 10.1002/prot.20810 · DOI · Paper page
  40. Capriotti, 2005, I-Mutant2.0: Predicting Stability Changes upon Mutation from the Protein Sequence or Structure, Nucleic Acids Res., 33, W306, 10.1093/nar/gki375 · DOI · Paper page
  41. Kitayner, 2006, Structural Basis of DNA Recognition by P53 Tetramers, Mol. Cell, 22, 741, 10.1016/j.molcel.2006.05.015 · DOI · Paper page
  42. Kastan, 1991, Participation of P53 Protein in the Cellular Response to DNA Damage, Cancer Res., 51, 6304
  43. Kastenhuber, 2017, Putting P53 in Context, Cell, 170, 1062, 10.1016/j.cell.2017.08.028 · DOI · Paper page
  44. Vousden, 2009, Blinded by the Light: The Growing Complexity of P53, Cell, 137, 413, 10.1016/j.cell.2009.04.037 · DOI · Paper page
  45. Collisson, 2014, Comprehensive Molecular Profiling of Lung Adenocarcinoma, Nature, 511, 543, 10.1038/nature13385 · DOI · Paper page
  46. Ng, 2015, R248Q Mutation—Beyond P53-DNA Binding, Proteins, 83, 2240, 10.1002/prot.24940 · DOI · Paper page
  47. Kern, 1992, Definition of a Consensus Binding Site for P53, Nat. Genet., 1, 45, 10.1038/ng0492-45 · DOI · Paper page
  48. Funk, 1992, A Transcriptionally Active DNA-Binding Site for Human P53 Protein Complexes, Mol. Cell. Biol., 12, 2866
  49. Friedman, 1993, The P53 Protein Is an Unusually Shaped Tetramer That Binds Directly to DNA, Proc. Natl. Acad. Sci. USA, 90, 3319, 10.1073/pnas.90.8.3319 · DOI · Paper page
  50. Weinberg, 2004, Cooperative Binding of Tetrameric P53 to DNA, J. Mol. Biol., 341, 1145, 10.1016/j.jmb.2004.06.071 · DOI · Paper page
  51. Inga, 2002, Differential Transactivation by the P53 Transcription Factor Is Highly Dependent on P53 Level and Promoter Target Sequence, Mol. Cell. Biol., 22, 8612, 10.1128/MCB.22.24.8612-8625.2002 · DOI · Paper page
  52. Maurer, 1998, Identification of a Novel Class of Genomic DNA-Binding Sites Suggests a Mechanism for Selectivity in Target Gene Activation by the Tumor Suppressor Protein P53, Genes Dev., 12, 2102, 10.1101/gad.12.14.2102 · DOI
  53. Andreou, 2007, TBX22 Missense Mutations Found in Patients with X-Linked Cleft Palate Affect DNA Binding, Sumoylation, and Transcriptional Repression, Am. J. Hum. Genet., 81, 700, 10.1086/521033 · DOI
  54. Saleem, 2001, Analyses of the Effects That Disease-Causing Missense Mutations Have on the Structure and Function of the Winged-Helix Protein FOXC1, Am. J. Hum. Genet., 68, 627, 10.1086/318792 · DOI
  55. Jain, 2021, Identification of Potential Inhibitors against Pathogenic Missense Mutations of PMM2 Using a Structure-Based Virtual Screening Approach, J. Biomol. Struct. Dyn., 39, 171, 10.1080/07391102.2019.1708797 · doi:10.1080/07391102.2019.1708797
  56. Magesh, 2021, Investigating Mutations at the Hotspot Position of the ERBB2 and Screening for the Novel Lead Compound to Treat Breast Cancer—A Computational Approach, Adv. Protein Chem. Struct. Biol., 123, 49, 10.1016/bs.apcsb.2020.10.001 · DOI
  57. Shoichet, 1995, A Relationship between Protein Stability and Protein Function, Proc. Natl. Acad. Sci. USA, 92, 452, 10.1073/pnas.92.2.452 · DOI · Paper page
  58. Sporleder, M., Zegarra, O., Hualla, V., Simon, R., and Kroschel, J. (2007, January 29–31). Phthorimaea Operculella Granulovirus: Sequenceanalysis of 5 Genes from 16 Geographical Isolates. Proceedings of the Brazilian Symposium on Bioinformatics, Angra dos Reis, Brazil.
  59. Joerger, 2007, Structure-Function-Rescue: The Diverse Nature of Common P53 Cancer Mutants, Oncogene, 26, 2226, 10.1038/sj.onc.1210291 · DOI · Paper page
  60. Rajendran, 2012, In Silico Investigation of Molecular Mechanism of Laminopathy Caused by a Point Mutation (R482W) in Lamin A/C Protein, Amino Acids, 43, 603, 10.1007/s00726-011-1108-7 · DOI · Paper page
  61. Bartlett, 1987, Evaluation of Intrinsic Binding Energy from a Hydrogen Bonding Group in an Enzyme Inhibitor, Science, 235, 569, 10.1126/science.3810155 · DOI · Paper page
  62. Machado, 2012, Proteopedia: 3D Visualization and Annotation of Transcription Factor–DNA Readout Modes, Biochem. Mol. Biol. Educ., 40, 400, 10.1002/bmb.20650 · DOI
  63. Kumar, 2021, Molecular Dynamics, Residue Network Analysis, and Cross-Correlation Matrix to Characterize the Deleterious Missense Mutations in GALE Causing Galactosemia III, Cell Biochem. Biophys., 79, 201, 10.1007/s12013-020-00960-z · DOI
  64. Piao, L., Chen, Z., Li, Q., Liu, R., Song, W., Kong, R., and Chang, S. (2019). Molecular Dynamics Simulations of Wild Type and Mutants of SAPAP in Complexed with Shank3. Int. J. Mol. Sci., 20. · DOI
  65. Nakazawa, 2019, Dominant-Negative P53 Mutant R248Q Increases the Motile and Invasive Activities of Oral Squamous Cell Carcinoma Cells, Biomed. Res., 40, 37, 10.2220/biomedres.40.37 · doi:10.2220/biomedres.40.37
  66. Gomes, A.S., Ramos, H., Inga, A., Sousa, E., and Saraiva, L. (2021). Structural and Drug Targeting Insights on Mutant P53. Cancers, 13. · DOI
  67. Stark, 2018, Therapeutic Ablation of Gain-of-Function Mutant P53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion, Cancer Cell, 34, 298, 10.1016/j.ccell.2018.07.004 · DOI · Paper page
  68. Orozco, 2002, Characterization of Disease-Associated Single Amino Acid Polymorphisms in Terms of Sequence and Structure Properties, J. Mol. Biol., 315, 771, 10.1006/jmbi.2001.5255 · DOI · Paper page
  69. Livesey, B.J., and Marsh, J.A. (2022). The Properties of Human Disease Mutations at Protein Interfaces. PLOS Comput. Biol., 18. · DOI
  70. Matthews, 1993, Structural and Genetic Analysis of Protein Stability, Annu. Rev. Biochem., 62, 139, 10.1146/annurev.bi.62.070193.001035 · DOI · Paper page
  71. David, 2015, The Contribution of Missense Mutations in Core and Rim Residues of Protein-Protein Interfaces to Human Disease, J. Mol. Biol., 427, 2886, 10.1016/j.jmb.2015.07.004 · DOI
  72. Li, 2006, FGFR3 Dimer Stabilization Due to a Single Amino Acid Pathogenic Mutation, J. Mol. Biol., 356, 600, 10.1016/j.jmb.2005.11.077 · doi:10.1016/j.jmb.2005.11.077
  73. Kamaraj, 2021, Effect of Novel Leukemia Mutations (K75E & E222K) on Interferon Regulatory Factor 1 and Its Interaction with DNA: Insights from Molecular Dynamics Simulations and Docking Studies, J. Biomol. Struct. Dyn., 39, 5235, 10.1080/07391102.2020.1784790 · DOI
  74. Sneha, P., Thirumal Kumar, D., George Priya Doss, C., Siva, R., and Zayed, H. (2017). Determining the Role of Missense Mutations in the POU Domain of HNF1A That Reduce the DNA-Binding Affinity: A Computational Approach. PLoS ONE, 12. · DOI
  75. Salsbury, 2010, Molecular Dynamics Simulations of Protein Dynamics and Their Relevance to Drug Discovery, Curr. Opin. Pharmacol., 10, 738, 10.1016/j.coph.2010.09.016 · DOI · Paper page
  76. Benz, 2005, Experimental Validation of Molecular Dynamics Simulations of Lipid Bilayers: A New Approach, Biophys. J., 88, 805, 10.1529/biophysj.104.046821 · DOI · Paper page
  77. Boeckler, 2008, Targeted Rescue of a Destabilized Mutant of P53 by an in Silico Screened Drug, Proc. Natl. Acad. Sci. USA, 105, 10360, 10.1073/pnas.0805326105 · DOI · Paper page
  78. Liu, 2013, Small Molecule Induced Reactivation of Mutant P53 in Cancer Cells, Nucleic Acids Res., 41, 6034, 10.1093/nar/gkt305 · DOI · Paper page
  79. Anderson, 2003, The Process of Structure-Based Drug Design, Chem. Biol., 10, 787, 10.1016/j.chembiol.2003.09.002 · DOI · Paper page
  80. The UniProt Consortium (2012). Reorganizing the Protein Space at the Universal Protein Resource (UniProt). Nucleic Acids Res., 40, D71–D75. · DOI · Paper page
  81. Berezin, 2004, ConSeq: The Identification of Functionally and Structurally Important Residues in Protein Sequences, Bioinformatics, 20, 1322, 10.1093/bioinformatics/bth070 · DOI · Paper page
  82. Landau, 2005, ConSurf 2005: The Projection of Evolutionary Conservation Scores of Residues on Protein Structures, Nucleic Acids Res., 33, W299, 10.1093/nar/gki370 · DOI · Paper page
  83. Berman, 2000, The Protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
  84. Guex, 1997, SWISS-MODEL and the Swiss-PdbViewer: An Environment for Comparative Protein Modeling, Electrophoresis, 18, 2714, 10.1002/elps.1150181505 · DOI · Paper page
  85. Jo, 2008, CHARMM-GUI: A Web-Based Graphical User Interface for CHARMM, J. Comput. Chem., 29, 1859, 10.1002/jcc.20945 · DOI · Paper page
  86. Vanommeslaeghe, 2010, CHARMM General Force Field: A Force Field for Drug-like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields, J. Comput. Chem., 31, 671, 10.1002/jcc.21367 · DOI · Paper page
  87. Jaidhan, 2014, Energy Minimization and Conformation Analysis of Molecules Using Steepest Descent Method, Int. J. Comput. Sci. Inf. Technol., 5, 4
  88. Berendsen, 1984, Molecular Dynamics with Coupling to an External Bath, J. Chem. Phys., 81, 3684, 10.1063/1.448118 · DOI · Paper page
  89. Parrinello, 1981, Polymorphic Transitions in Single Crystals: A New Molecular Dynamics Method, J. Appl. Phys., 52, 7182, 10.1063/1.328693 · DOI · Paper page
  90. Kumari, 2014, G_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations, J. Chem. Inf. Model., 54, 1951, 10.1021/ci500020m · DOI · Paper page
  91. Desdouits, 2015, Principal Component Analysis Reveals Correlation of Cavities Evolution and Functional Motions in Proteins, J. Mol. Graph. Model., 55, 13, 10.1016/j.jmgm.2014.10.011 · DOI

Cited by

See all 18

Metadata

Authors
Balasundaram, A., & Doss, C. G. P.
Affiliations
Laboratory of Integrative Genomics, Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-12-07
Volume
23
Issue
24
Pages
15499
ISSN
1422-0067
Cited by
18
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unraveling the Structural Changes in the DNA-Binding Region of Tumor Protein p53 (TP53) upon Hotspot Mutation p53 Arg248 by Comparative Computational Approach. https://app.cochat.ai/papers/10.3390/ijms232415499
The paper
Balasundaram, A., & Doss, C. G. P. (2022). Unraveling the Structural Changes in the DNA-Binding Region of Tumor Protein p53 (TP53) upon Hotspot Mutation p53 Arg248 by Comparative Computational Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms232415499

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.